According to the new 2021 World Health Organization (WHO) classification of tumors of the central nervous system (CNS) the classification of the primary intramedullary spinal cord tumors (IM-SCT) follows that of CNS tumors. However, since the genetics and methylation profile of ependymal tumors depend on the location of the tumor, the ‘spinal (SP)’ should be added for the ependymoma (EPN) and subependymoma (SubEPN). For an evidence-based review, the authors reviewed SCTs in the archives of the Seoul National University Hospital over the past decade. The frequent pathologies of primary IM-SCT were SP-EPN (45.1%), hemangioblastoma (20.0%), astrocytic tumors (17.4%, including pilocytic astrocytoma [4.6%] and diffuse midline glioma, H3 K27-altered [4.0%]), myxopapillary EPN (11.0%), and SP-subEPN (3.0%) in decreasing order. IDH-mutant astrocytomas, oligodendrogliomas, glioneuronal tumors, embryonal tumors, and germ cell tumors can occur but are extremely rare in the spinal cord. Genetic studies should support for the primary IM-SCT classification. In the 2021 WHO classifications, extramedullary SCT did not change significantly but contained several new genetically defined types of mesenchymal tumors. This article focused on primary IM-SCT for tumor frequency, age, sex difference, pathological features, and genetic abnormalities, based on a single-institute experience.
Citations
Citations to this article as recorded by
Outcomes of initially chosen non-operative management for spinal ependymoma Guang-Hao Zheng, Yao-Wu Zhang, Kai Ji, Hui Qiao, Xiao Wu, Yi-Xiang Liu, Wei-Hao Liu, Bo Wang, Chong Wang, Xing-Yu Liu, Yong-Zhi Wang, Wen-Qing Jia Journal of Clinical Neuroscience.2026; 144: 111780. CrossRef
Minimally invasive approaches to intramedullary spinal cord tumors: a systematic review of techniques and outcomes Nadir Al-Saidi, Dina Mohammed, Zainab Fatima, Ali Haider Bangash, Saikiran G. Murthy, Yaroslav Gelfand, Reza Yassari, Rafael De la Garza Ramos European Spine Journal.2026;[Epub] CrossRef
Sodium Fluorescein-Guided Microsurgery for Intramedullary Spinal Ependymomas: Technical Nuances, Surgical Workflow, and Operative Video Silvia Michelini, Amer A. Alomari, Flavia Fraschetti, Ettore Carpineta, Luciano Mastronardi World Neurosurgery.2026; 212: 125092. CrossRef
Neurological complications of CAR T cell therapy for cancers Philipp Karschnia, Jörg Dietrich Nature Reviews Neurology.2025; 21(8): 422. CrossRef
RETRACTED ARTICLE: DQSCTC: design of an efficient deep dyna-Q network for spinal cord tumour classification to identify cervical diseases Nilesh P. Sable, Priti Shende, Vishal Ashok Wankhede, Kishor S. Wagh, J. V. N. Ramesh, Sunita Chaudhary Soft Computing.2024; 28(S2): 733. CrossRef
Incidence and Survival of Patients With Malignant Primary Spinal Cord Tumors: A Population-Based Analysis Huanbing Liu, Linnan Duan, Zhibin Li, Yuanhao Liu, Yubo Wang Neurospine.2024; 21(2): 588. CrossRef
The Role of Radiotherapy, Chemotherapy, and Targeted Therapies in Adult Intramedullary Spinal Cord Tumors Ines Esparragosa Vazquez, François Ducray Cancers.2024; 16(16): 2781. CrossRef
Astrocytomas of the spinal cord Joerg-Christian Tonn, Nico Teske, Philipp Karschnia Neuro-Oncology Advances.2024; 6(Supplement): iii48. CrossRef
To Seek Appropriate Management for Intramedullary Spinal Cord Tumor: Commentary on Special Issue “Spinal Intramedullary Tumor” Toshiyuki Takahashi, Tomoo Inoue Neurospine.2023; 20(3): 733. CrossRef
First
Prev
